Ryzodeg

insulin degludec / insulin aspart

Used for Diabetes Type 1, Diabetes Type 2, Gestational Diabetes

Ryzodeg is an injection medication containing two different types of insulin. But, it's discontinued and is no longer available in the U.S.

Reviewed by:

Hope Chang, PharmD, AAHIVP

Allison Gourley, PharmD

Last reviewed on November 15, 2021

What is Ryzodeg?

Drug facts

Common Brands	Ryzodeg 70/30
Drug Class	Insulin
Controlled Substance Classification	Not a controlled medication
Generic Status	No lower-cost generic available
Availability	Discontinued

Common Brands

Ryzodeg 70/30

Drug Class

Insulin

Controlled Substance Classification

Not a controlled medication

Generic Status

No lower-cost generic available

Availability

Discontinued

Common questions about Ryzodeg

Ryzodeg is a combination insulin injection used for the treatment of type 1 and type 2 diabetes. It contains a long-acting insulin (insulin degludec) and a fast-acting insulin (insulin aspart). As a combination medication, it can lower the number of insulin injections needed every day.

No, Ryzodeg is not available in the U.S. because it was discontinued.

It's not clear why Ryzodeg was discontinued. But, it doesn't appear to be discontinued due to safety concerns.